Skip to main content
. 2016 Aug 12;9(3):3112–3120. doi: 10.18632/oncotarget.11258

Figure 2. Kaplan-Meier analyses for overall survival and recurrence free survival of patients with ccRCC according to ST6GalNAc-1 expression.

Figure 2

Overall survival according to ST6GalNAc-1expression in non-metastatic ccRCC patients A. recurrence free survival according to ST6GalNAc-1expression in non-metastatic ccRCC patients B. p-value was calculated by Log rank test, p<0.05 was regarded as statistically significant.